Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
23/02/2026 12:36
Feb 23 (Reuters) - PCI Biotech Holding ASA PCIB.OL: PROPOSES DISSOLUTION AND DELISTING FROM EURONEXT OSLO BØRS TO HOLD EXTRAORDINARY GENERAL MEETING ON MAR 16, 2026 WHOLLY OWNED SUBSIDIARY, PCI BIOTECH AS, HAS TODAY RESOLVED TO INITIATE A PARALLEL DISSOLUTION PROCESS BOARD PROPOSES DELISTING DUE TO LIMITED ASSETS AND NO ACTIVITY Source text: ID:nGNE3kS0xx Further company coverage: PCIB.OL (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process